share_log

Recent 17% Pullback Isn't Enough to Hurt Long-term Shandong Fengyuan Chemical (SZSE:002805) Shareholders, They're Still up 95% Over 5 Years

Recent 17% Pullback Isn't Enough to Hurt Long-term Shandong Fengyuan Chemical (SZSE:002805) Shareholders, They're Still up 95% Over 5 Years

最近17%的回调不足以伤害山东丰源化学(SZSE:002805)的长期股东,他们在5年内仍上涨了95%
Simply Wall St ·  01/30 17:12

Some Shandong Fengyuan Chemical Co., Ltd. (SZSE:002805) shareholders are probably rather concerned to see the share price fall 33% over the last three months. On the bright side the returns have been quite good over the last half decade. Its return of 93% has certainly bested the market return! While the long term returns are impressive, we do have some sympathy for those who bought more recently, given the 62% drop, in the last year.

一些山东丰源化工有限公司(SZSE:002805)股东可能对股价在过去三个月中下跌33%感到担忧。好的一面是,在过去的五年中,回报率相当不错。其93%的回报率无疑超过了市场回报率!尽管长期回报令人印象深刻,但鉴于去年下降了62%,我们对最近买入的人有些同情。

While this past week has detracted from the company's five-year return, let's look at the recent trends of the underlying business and see if the gains have been in alignment.

尽管过去一周减损了该公司的五年回报率,但让我们来看看基础业务的最新趋势,看看涨幅是否一致。

Check out our latest analysis for Shandong Fengyuan Chemical

查看我们对山东丰源化工的最新分析

Because Shandong Fengyuan Chemical made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

由于山东丰源化工在过去十二个月中出现亏损,我们认为至少目前市场可能更加关注收入和收入增长。一般而言,没有利润的公司预计每年收入将增长,而且速度很快。一些公司愿意推迟盈利以更快地增加收入,但在这种情况下,人们确实预计收入会有良好的增长。

In the last 5 years Shandong Fengyuan Chemical saw its revenue grow at 49% per year. That's well above most pre-profit companies. While the compound gain of 14% per year is good, it's not unreasonable given the strong revenue growth. If you think there could be more growth to come, now might be the time to take a close look at Shandong Fengyuan Chemical. Of course, you'll have to research the business more fully to figure out if this is an attractive opportunity.

在过去的5年中,山东丰源化工的收入以每年49%的速度增长。这远高于大多数盈利前公司。尽管每年14%的复合收益不错,但考虑到强劲的收入增长,这并非不合理。如果你认为未来可能会有更多的增长,那么现在可能是仔细研究山东丰源化工的时候了。当然,你必须对业务进行更全面的研究,以确定这是否是一个有吸引力的机会。

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

您可以在下图中看到收入和收入随时间推移而发生的变化(点击图表查看确切值)。

earnings-and-revenue-growth
SZSE:002805 Earnings and Revenue Growth January 30th 2024
SZSE: 002805 收益和收入增长 2024 年 1 月 30 日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. This free interactive report on Shandong Fengyuan Chemical's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

可能值得注意的是,首席执行官的薪水低于类似规模公司的中位数。始终值得关注首席执行官的薪酬,但更重要的问题是公司多年来是否会增加收益。如果你想进一步调查该股,这份关于山东丰源化工收益、收入和现金流的免费互动报告是一个很好的起点。

A Different Perspective

不同的视角

We regret to report that Shandong Fengyuan Chemical shareholders are down 62% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 20%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. On the bright side, long term shareholders have made money, with a gain of 14% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For instance, we've identified 2 warning signs for Shandong Fengyuan Chemical (1 shouldn't be ignored) that you should be aware of.

我们遗憾地报告,山东丰源化工的股东今年下跌了62%(甚至包括股息)。不幸的是,这比整个市场20%的跌幅还要严重。但是,可能只是股价受到了更广泛的市场紧张情绪的影响。如果有很好的机会,可能值得关注基本面。好的一面是,长期股东赚了钱,在过去的五年中,每年增长14%。最近的抛售可能是一个机会,因此可能值得查看基本面数据以寻找长期增长趋势的迹象。我发现将长期股价视为业务绩效的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。例如,我们已经确定了山东丰源化工的两个警告信号(其中一个不容忽视),你应该注意这些信号。

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

对于那些喜欢寻找中奖投资的人来说,这份最近有内幕收购的成长型公司的免费名单可能只是门票。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发